Related Experiment Video
Updated: Jun 23, 2026
05:28
A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
[Multi-target therapeutics and new drug discovery]
1Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|May 20, 2009
Summary
Multitarget therapeutics offer improved efficacy and reduced resistance for complex diseases like cancer and diabetes compared to single-target drugs. This review explores their development, clinical use, and the potential of Traditional Chinese Medicine (TCM) in this field.
Area of Science:
- Pharmacology
- Drug Discovery
- Systems Biology
Context:
- Complex diseases like cancer, diabetes, and inflammation involve multiple molecular targets, making single-target drugs often insufficient.
- Traditional single-target drug therapies can lead to unsatisfactory therapeutic effects and severe toxicity.
- A systems biology approach is crucial for understanding and treating complex diseases.
Purpose:
- To review the characteristics, classification, and development strategies of multitarget therapeutics.
- To explore screening models and current clinical applications of multitarget drugs.
- To investigate the potential of Traditional Chinese Medicine (TCM) in multitarget drug development.
Summary:
- Multitarget therapeutics simultaneously regulate multiple nodes in a disease network, offering synergistic effects and reduced resistance.
- This approach is advantageous for treating complex diseases where single-target interventions are inadequate.
- The review covers development strategies, screening methods, existing clinical drugs, and the role of TCM.
Impact:
- Highlights the advantages of multitarget therapeutics over single-target drugs for complex diseases.
- Provides a comprehensive overview of multitarget drug development and clinical applications.
- Suggests TCM as a potential source for novel multitarget therapeutic strategies.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...